Well if you have been paying attention old mate you would have a better understanding…….All we need to be concerned about is a green light for a phase 3 trial, plenty of big Pharmas throughout the world who would love to break into the HIV space if it will give them a return on their investment, or maybe the big Pharmas in the HIV space don’t want that Lol or maybe the big Pharma companies in the HIV space would like a new drug for themselves. Anyhow outstanding results will generate a lot of interest.
COVID19 - competitive landscape, page-191
-
- There are more pages in this discussion • 168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
